moclobemide has been researched along with pancuronium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chambost, M; Combe, C; Liron, L; Peillon, D | 1 |
2 other study(ies) available for moclobemide and pancuronium
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
[Serotonin syndrome during fluoxetine poisoning in a patient taking moclobemide].
Topics: Adult; Anesthetics, Intravenous; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzodiazepines; Female; Fentanyl; Fluoxetine; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Pancuronium; Respiration, Artificial; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Thiopental | 2000 |